On April 30, 2014, Synthetic Biologics Inc (NYSEMKT:SYN), released that the University of California, Los Angeles (UCLA) School of Medicine declared preliminary, optimistic topline data from the Phase II clinical trial evaluating Trimesta (oral estriol), the Company’s oral, once-daily treatment for relapsing-remitting multiple sclerosis (RRMS) in women. Synthetic Biologics Inc (NYSEMKT:SYN), shares after opening at $1.33 moved to $1.44 on last trade day and at the end of the day closed at $1.42. Company price to cash ratio as 5.67. Synthetic Biologics Inc (NYSEMKT:SYN), showed a positive weekly performance of 11.95%.
On May 02, 2014, Odyssey Marine Exploration Inc (NASDAQ:OMEX), a pioneer in the field of deep-ocean exploration, will hold a conference call on Tuesday, May 13, 2014, at 11:00 a.m. Eastern time to discuss results for the first quarter ended March 31, 2014. Financial results will be issued in a press release prior to the call. Odyssey Marine Exploration Inc (NASDAQ:OMEX), shares advanced 7.58% in last trading session and ended the day on $2.27. Odyssey Marine Exploration Inc (NASDAQ:OMEX), return on assets is -29.70%. Odyssey Marine Exploration Inc (NASDAQ:OMEX), yearly performance is -19.79%.
Kandi Technologies Group Inc (NASDAQ:KNDI), announced that Zhejiang Kandi Vehicles Co., Ltd. (“Kandi Vehicles”), the Company’s wholly-owned subsidiary in China, signed a supply contract with Lishen Battery System Co., Ltd (“Tianjin Lishen”), China’s largest producer of rechargeable lithium-ion batteries, for a one-year supply, a minimum of 25,000 cases, of 80V/70AH lithium-ion batteries starting in May 2014. Kandi Technologies Group Inc (NASDAQ:KNDI), shares moved up 9.02% in last trading session and was closed at $12.33, while trading in range of $ 11.07 – 12.43. Kandi Technologies Group Inc (NASDAQ:KNDI), year to date (YTD) performance is 4.58%.
On April 29, 2014, Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), provided an update on its first quarter 2014 and recent business activities. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), weekly performance is 22.32%. On last trading day company shares ended up $12.44. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), distance from 50-day simple moving average (SMA50) is -0.28%. Analysts mean target Price for the company is $14.24.
Leave a Reply